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Abstract
Background: Increasing access to antiretroviral therapy (ART) is a critical goal endorsed by the
United Nations and all of its member states. At the same time, anecdotal accounts suggest that the
promotion of unproven AIDS 'cures' and remedies are widespread, and in the case of The Gambia,
Iran and South Africa, have been promoted by governments directly. Although a range of legislative
and regulatory measures have been adopted by some governments, and technical assistance has
been provided by international agencies to address counterfeit medicines generally, the threat of
counterfeit antiretroviral drugs is not being addressed.
Discussion: Countries, charged with fulfilling the right to health and committed to expanding
access to ART must explicitly recognize their obligation to combat unproven AIDS treatments and
ensure the availability of a safe and efficacious drugs supply. International donors must help support
and coordinate these efforts.
Background
In the last few years governments around the world have
pledged to massively scale up the delivery of antiretroviral
drugs (ARVs) to achieve universal access to all. To date
attention has focused on how to finance this effort and
how to strengthen health care delivery systems, including
how to conduct mass HIV testing programs and increase
the number of health care providers worldwide. Less
attention has been paid to the responsibilities of govern-
ments and international agencies to address the wide-
spread prevalence of unproven AIDS 'cures' and the threat
of counterfeit ARVs.
Marketing AIDS 'cures'
Treatments to cure HIV/AIDS have been falsely promoted
since AIDS was first identified and claims of cures con-
tinue in spite of the development of ARVs, which can dra-
matically slow the progression to AIDS but do not rid the
body of HIV. The uncertainty and fear engendered by this
incurable, stigmatizing and life-threatening disease can
make people easy prey to promises of cures. But in addi-
tion to fear, there are specific factors, related to govern-
ment functioning, that facilitate false claims of HIV cures,
including: little or no access by people living with HIV
and those populations most at risk to health care generally
and ARVs specifically; stigmatizing and discriminatory
treatment of people living with HIV/AIDS (PLWHA) in
health care settings; high prices for legitimate pharmaceu-
ticals when available; little or no regulatory oversight over
the fields of traditional medicine and complementary
treatments; and a lack of promotion by governments of
the availability and efficacy of ARVs.
In some cases, government endorsement of unproven
'cures' has created confusion regarding the legitimacy of
AIDS medicines, and governments and international
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appropriate recognition of the important role played by
traditional medicines in physical and psychosocial care,
[1,2] from the dangerous and modern day hucksterism
that AIDS 'cures' represent.
It is important at the outset to differentiate between legit-
imate and fraudulent promotion of herbal and other rem-
edies. While there is very little data documenting the
global use of herbal remedies, nutritional supplements,
and traditional medicines, they are believed to be widely
used by PLWHA to enhance their wellbeing. Unproven
AIDS 'cures', on the other hand purport not just to
enhance wellbeing but to specifically eradicate HIV. Less
clearly definable is the promotion of HIV treatments
which fall short of promising a 'cure' but advertise specific
health benefits or biologic effects. Some of these, for
example those that promote general immune boosting,
may be considered akin to a supplement. Others, such as
those which suggest an impact on HIV viral load are more
properly considered a medicine or 'treatment'. Despite
being promoted as 'traditional' or 'herbal', many supple-
ments, 'cures', and treatments are produced using modern
mass manufacturing techniques and with industrial
chemicals.
Examples of unproven AIDS 'cures' and treatments can be
found in the United States, Zambia, Mexico, South Africa,
Thailand, India, Zimbabwe, and elsewhere. In the US for
example, an orthopedic surgeon promoted an intrave-
nous product containing aloe vera to treat AIDS and can-
cer, netting as much as US$18,000 for each 2-week
treatment [3]. In Zambia, a 'cure' for AIDS called Tetrasil
was promoted by a Zambian newspaper editor who held
an ownership stake in the product with a prominent US
AIDS denialist. The product was found to be a pesticide
used to clean swimming pools [4]. Some PLWHA aban-
doned their ART for the drug [5]. 'Oxytherapy', using
ozone, has been touted as a treatment for both cancer and
AIDS in countries as diverse as Mexico and South Africa
[6], and hyperthermia via high temperature baths has
been increasingly promoted. In 2006 the South African
drug regulatory agency said that "unregistered products
claiming to cure HIV/AIDS, tuberculosis and various
forms of cancer were readily obtained from street ven-
dors" [7]. In Thailand, the Salang Bunnag Foundation
handed out thousands of bottles of 'V-1 Immunitor',
which was promoted as a cure for AIDS [8]. In Zimbabwe,
the herbal remedy 'guandamiti' – developed with support
from the United Nations Educational, Scientific and Cul-
tural Organization (UNESCO), Kellogg Foundation, the
US National Cancer Institute and the World Health
Organization – has been promoted as significantly reduc-
ing viral load (variously reported as 60–76% or 90%) and
opportunistic infections [9]. None of the organizations
supporting its development have spoken out against its
unproven claims.
Despite widespread anecdotal evidence of openly mar-
keted AIDS 'cures', little quantitative research has been
done to assess the use of unproven treatments by PLWHA
or the overlapping or concomitant use of ART and tradi-
tional medicines. One survey of PLWHA in India found
that 64% had heard about a traditional treatment to cure
HIV. Of those who had heard of a 'cure', 78% had tried the
treatment [10]. By contrast, a study in Gabon of current
patients at a medical clinic found that traditional healers
were consulted first after the onset of HIV symptoms only
5% of the time, but 17% of patients sought concomitant
therapy with traditional medicine and 3% sought faith
healing [11]. Ethnographic research in Uganda [12] and
South Africa [13] suggest a complex and chaotic process of
treatment seeking on the part of PLWHA.
Government responses to AIDS 'cures'
The most common response by governments to the prob-
lem of unproven AIDS treatments has been inaction. Due
to the initial unavailability of ARV drugs, many govern-
ments did not promote ART as effective and life-saving
and warn that other treatments are unproven and poten-
tially dangerous. But even as ARV drugs have become
more available, their still limited supply and the often
complex and politically charged relationship between
governments and traditional medical providers has
caused governments to hesitate from aggressively promot-
ing ART and challenging other claims. Even those govern-
ments that adopt pragmatic and 'progressive' AIDS
policies promoting the open discussion of sexuality or the
promotion of women's rights may find that criticizing
unproven AIDS cures can be misunderstood as criticizing
traditional medicines and can be politically risky. Conse-
quently, most governments do nothing as 'cures' are pro-
moted openly – in newspapers, on the radio, on
billboards and other outlets.
In some cases governments have acted under pressure
from civil society or the media. In Zambia, the govern-
ment investigated the promotion of the purported 'cure'
Tetrasil, and banned the advertisement and sale of the
drug. In addition, a law was passed requiring that all drugs
and natural remedies be tested for safety and efficacy,
whether they are medicines or locally available herbs [5].
In Thailand, in response to the promotion of V-1 Immu-
nitor, the Thai Ministry of Health tested 50 patients taking
the medicine, and reported that the pills had no effect on
their immune systems. Despite the fact that the pills were
being promoted as a 'cure', the government found that the
pills were not toxic and could be marketed as a food sup-
plement [8].Page 2 of 10
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unproven treatments. The President of The Gambia has
promoted a product which he claimed could cure AIDS,
diabetes and asthma [14]. Iran's health minister, Kamran
Baqeri Lankarani, announced that Iranian researchers had
developed a medicine made completely with Iranian
native plants that boosts the immune system and slows
the replication of HIV [15]. Although the Minister does
not appear to have referred to the remedy as a "cure", press
reports from the region do [16] and it has been promoted
by the Iranian Institute for AIDS Research as a "therapeu-
tic vaccine" [17]. In both The Gambia and Iran, allega-
tions have been made that government health officials
have switched people to these unproven remedies from
ART without their consent. Perhaps the most well known
example of governments promoting alternatives to effec-
tive ARV medicines has been the government of South
Africa, where President Thabo Mbeki and his health min-
isters have notoriously used their authority to challenge
the use of ART and promote unproven therapies [18].
The Gambia
The claim by Yahya Jammeh, President of The Gambia,
that he can cure HIV exemplifies the flagrant abuse of
power and influence by a government leader. President
Jammeh claims his secret concoction of herbs will cure
AIDS in three days if people taking the treatment also dis-
continue taking ART and refrain from alcohol, caffeine
and sex [19]. The consequences of criticizing the President
have proven risky. Two journalists were fired by the owner
of a pro-government newspaper in February 2007 after
writing about the 'cure' [20]. Although reinstated, one of
the journalists was subsequently fired by the paper in July
after writing about it again [21]. A more prominent critic,
the UN resident coordinator in The Gambia, Fadzai
Gwaradzimba, was permanently expelled for asking for
scientific proof of the treatment's effectiveness in a TV
interview [22]. She also pointed out that his claims of a
cure might encourage people to engage in risky behavior.
President Jammeh also turned to a respected Senegalese
AIDS scientist, Prof. Souleyman Mboup, for support of his
claim of a 'cure'. Jammeh publicly announced that tests
conducted by Mboup confirmed that the treatment was
successful. But in a statement released through the Inter-
national AIDS Society (IAS) and the Society for AIDS in
Africa, Mboup refuted this assertion and said that a visit-
ing laboratory technician had independently run tests in
his lab, and that no conclusion of effectiveness could be
drawn [23].
In response to Jammeh's claims, the WHO and UNAIDS
issued a statement reiterating that there is no cure for
AIDS and warning that substituting untested remedies for
evidence-based treatments could have adverse effects [24].
The statement encouraged President Jammeh to collabo-
rate with international efforts to scientifically assess the
safety, efficacy and quality of the remedy, but Jammeh
refuses to allow samples of his herbs to be removed from
the country to be tested. The WHO/UNAIDS statement
appears to have been the extent of international pressure:
the UN replaced the expelled envoy and has issued no fur-
ther public statements.
Iran
On February 11, 2007, the President of Iran, Mahmoud
Ahmadinejad, announced a series of technological and
medical breakthroughs and asserted the country's nuclear
"rights". Within this highly politicized announcement,
President Ahmadinejad announced a new treatment for
AIDS [25]. The treatment, an herbal medicine made from
seven "completely native" Iranian herbs, was named
IMOD, an abbreviation for "immuno-modulator drug",
and developed by a Russian scientist and tested by the Ira-
nian Research Center for HIV/AIDS. The Center's English
language website does not directly state that the herbal
remedy is a 'cure' but suggests that IMOD could be used as
a "therapeutic vaccine" and as the "first choice" for treat-
ment in resource constrained developing countries [17].
At the announcement ceremony, Iran's top AIDS expert
and head of the research center, Minoo Mohraz, stated
that, "a medicine that is used for curing AIDS [emphasis
added], should be completely secure and reliable", and
stated that this is true in the new medicine [15].
The announcement of the new treatment by President
Ahmadinejad was accompanied by the awarding to the
Minister of Health a national medal of honor, while scien-
tists protesting the testing of the remedy against a placebo
control group have been censured or fired. The President's
Office for Technology Cooperation has subsequently pro-
moted the remedy and sought partners for joint market-
ing, clinical trials and manufacturing, and stated that it
was available for export.
Four months after the first public announcement of the
remedy, Christian Salazar, UNICEF's coordinator on HIV
in Iran, praised the country's "progressive and pragmatic"
efforts in fighting the virus that causes AIDS, but said
nothing about IMOD [26] and no further comments from
UNAIDS, WHO or other governments have been made.
South Africa
The government of South Africa's unwillingness to
acknowledge the effectiveness of ART and outright ques-
tioning of the relationship between HIV and AIDS has
been extensively reported [18]. The consequences to pub-
lic health in terms of the delayed introduction of effective
medicine to treat HIV infection and the continuing lack of
trust in ART has been less well documented, as have thePage 3 of 10
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officials and promoters of vitamins and herbal remedies.
Three noteworthy examples include the cases of 'Viro-
dene', an industrial solvent promoted by a pair of Univer-
sity of Pretoria scientists, and the nutritional supplements
and extracts promoted by the German Matthias Rath and
the Dutch Tine van der Maas.
In early 1997, the Minister of Health, Nkosazana
Dlamini-Zuma, met with two University of Pretoria scien-
tists promoting 'Virodene' a drug composed of the toxic
industrial solvent dimethylformamide as a 'cure' for AIDS
[27]. The Health Minister in turn invited the scientists to
a cabinet meeting where cabinet ministers heard from the
scientists and patients who had taken the drug as part of
an unauthorized clinical trial. Cabinet Secretary Jakes Ger-
wel was impressed by the effectiveness of the 'cure': "The
patients said they were dying, they got this treatment, and then
they were saved!" [28].
Thabo Mbeki, acting as the deputy President, chaired the
meeting, and shared the enthusiasm of Gerwel. However,
a major obstacle to the further promotion of the 'cure' was
the refusal by the government's independent Medicines
Control Council (MCC) to provide permission for the
continuation of the clinical trial, due to the known toxic-
ity and lack of effectiveness of dimethylformamide. Even-
tually the Minister of Health was able to replace key MCC
members [27], however official approval was still not pro-
vided. Nonetheless, the researchers continued, without
ethical approval, to test the drug in South Africa [6] and
Tanzania [29].
Both Mbeki and his two health ministers have referred to
ART as 'toxic' and promoted alternatives to ART, including
garlic, olive oil, beetroot and lemon. The doctor Matthias
Rath who has offices in Germany, the Netherlands and
California, has had close ties to Mbeki and his administra-
tion. In 2005 Rath promoted his nutritional supplements
and criticisms of ART via newspaper advertisements in
South Africa (entitled "Stop AIDS Genocide by the Drug
Cartel") and directly in poor townships around Cape
Town. Despite the resulting controversy and calls for a
government response, the Ministry of Health refused to
contest the claims and unequivocally defend the effective-
ness of ART [30].
The Minister of Health also promoted an herbal treatment
developed by a Dutch nurse composed of African potato
extract, olive green leaf extract, and grapefruit seed extract
called 'Africa's Solution'. Tshabalala-Msimang invited the
remedy's developer to address provincial health ministers
and arranged for the provision of the solution to AIDS
patients in government hospitals and clinics[31]. Alleg-
edly, the solution was given to over 40,000 people, but
the records were destroyed when a burglar urinated on
them [32]. Tshabala-Msimang also arranged for a Health
ministry advisor to work directly with the manufacturer at
government expense [33]. At the 2006 International AIDS
Conference in Toronto, the official South African govern-
ment display booth included garlic, lemon and beetroot.
Only at the protest of South African AIDS activists were
boxes of ART added.
There has been considerable speculation as to the motiva-
tion of Mbeki and Tshabalala-Msimang. Some have ques-
tioned whether the rejection of the use of AZT might be
due to a desire to promote nationally-developed drugs
[34]. It was also reported that Mbeki's party, the African
National Congress, was to receive 6% of the shares in CPT,
the company that manufactures Virodene [35]. South
African newspapers have reported that tens of millions of
South African Rand were paid for the Virodene trials
directly from the Office of the Presidency [36].
The UN's response in South Africa has been typical: issu-
ing occasional press releases but not otherwise seeking to
counteract the promotion of unproven AIDS 'cures'. UN
agencies in South Africa called Rath's advertisements
"wrong and misleading" and said Rath's implication that
the UN agencies supported his nutritional approach were
"dangerous and unhelpful" [37] but have been silent on
other proposed 'cures' such as Ubejane or Secomet V, both
widely promoted as 'cures' in the past two years. Mean-
while, HIV test counselors and health clinic staff partici-
pate in the promotion of unproven 'cures' and
supplements [38].
Counterfeit ARVs
According to the WHO, a counterfeit drug is "one which
is deliberately and fraudulently mislabeled with respect to
identity and/or source. Counterfeiting can apply to both
branded and generic products and counterfeit products
may include products with the correct ingredients or with
the wrong ingredients, without active ingredients, with
insufficient active ingredients or with fake packaging"
[39]. Counterfeited drugs may have little or no therapeu-
tic value, causing illness and death from the condition
supposedly being treated, or the fake drugs may be com-
posed of toxic substances that directly cause illness and
death. Counterfeited drugs with the appropriate active
ingredients in subclinical amounts can also lead to pro-
longed illness or death, but pose the further risk of
encouraging the spread of drug resistant pathogens.
Although much counterfeit drug trade occurs in the unreg-
ulated market of unofficial drug vendors, especially in
developing countries, counterfeit drugs are also found
extensively in licensed pharmacies.Page 4 of 10
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tries to large factories and can involve smuggling and ille-
gal importation, use of fictitious businesses and front
companies, and false documents. Counterfeiters have
become extremely sophisticated in mimicking branded
medicines, creating nearly identical packaging and pills
and using false batch code information. These fake drugs
easily pass customs inspections and are accepted and dis-
tributed by pharmaceutical supply companies and phar-
macies.
Like unproven 'cures', the true extent of counterfeit drugs
has not been fully documented. Investigative journalism
provides the preponderance of information on counter-
feiting compared with relatively scant treatment in the sci-
entific and public health literature [40]. However, unlike
unproven 'cures', governments and international agencies
have estimated the prevalence of counterfeit medicines.
The US Food and Drug Administration estimates that
counterfeit drugs account for 10% of the international
market and according to the WHO the proportion may be
25% of the market in developing countries [41]. The Inter-
national Narcotics Control Board has warned that up to
half of all prescription narcotics in developing countries
may be counterfeit [42]. In Nigeria, before 2006, health
officials estimated that 70% of drugs in circulation in the
country were either fake or adulterated [43].
It is difficult to assess the true prevalence of counterfeit
ARVs, in part because of the lack of specific research, but
also because anecdotal reports of counterfeit ARVs are
sometimes mixed with reports of unproven cures or
authentic ART smuggled from other countries or illegally
diverted from medical supplies. Nonetheless, a number of
factors make ART an attractive target for counterfeiters,
especially: high unit costs and long-term, sustained
demand. In addition, stigma and fear of loss of confiden-
tiality in health care settings increase demand for ARVs
delivered through often poorly regulated private sector
health care providers, pharmacies or other channels.
In 2004 the Kenyan newspaper 'The Nation' documented
an active informal market for ARVs, including AIDS cures
and counterfeit drugs, in Tsavo Road in Nairobi [44]. A
2003 report from Ethiopia found illegally imported "con-
coctions" being marketed as ART [45]. With the collapse
of the economy and medical system in Zimbabwe have
come reports of ART stolen from the public health care
system and smuggled from neighboring countries [46]
and individuals switching from ART to herbal reme-
dies[47]. The Zimbabwean Health and Child Welfare
Minister said that ART were being sold at flea markets and
hair salons and called on civil society organizations to
help "evaluate" the problem. In Burma, where it is esti-
mated that only 7% of individuals living with HIV who
need ARVs have access to them [48], the UNAIDS Country
Coordinator stated that he was aware of no programs to
monitor for counterfeit ARV drugs. Assessing the risk of
the emergence of counterfeit ARVs in the country, he
stated: "Everything else in Burma is counterfeit. It's only a
matter of time before ARVs are too." [B. Williams, personal
communication]
The trafficking of counterfeit ARVs has been specifically
documented in two cases to date. In 2003 the WHO
issued an alert that a product called 'Ginovir 3D', mar-
keted in Cote d'Ivoire as a triple ARV combination prod-
uct, contained only one of the drugs (zidovudine) on the
label, none of the other 2 drugs (lamivudine and indina-
vir), and an additional drug not on the label (stavudine)
[49]. In 2004 Medecins Sans Frontieres (MSF) discovered
counterfeit ARVs on the market in the Democratic Repub-
lic of Congo that contained an antidepressant and a mus-
cle relaxant [50]. Whether the lack of more recent cases is
due to the increased availability of ART or some other fac-
tor, or is simply due to the lack of close monitoring is
unknown.
Unlike the merely rhetorical response by governments
and UN agencies to unproven 'cures', a range of actions
have been taken at both levels to combat the proliferation
of counterfeit medicines. Governments have adopted and
refined legislation opposing counterfeiting and have tar-
geted specific highly counterfeited medicines with special
protections (including packaging, price management, reg-
ulation, law enforcement). International agencies have
led regional and international initiatives aimed at sharing
information and reporting incidences of trafficking, and
have provided technical support to countries and regional
coalitions.
To address the high levels of the counterfeit anti-malaria
drug artesunate in Thailand, most malaria is treated at no
cost in government malaria clinics where drug supplies
can be more closely monitored [51]. In China, national
pharmaceutical laws were strengthened in 2001, includ-
ing strict controls on price management, manufacturing
registration, import inspections, and law enforcement
[52]. However, corruption and the lack of protection for
whistleblowers undermined China's attempt to establish
a more rigorous drug regulatory system, and the 2001
laws did not apply to drugs manufactured in China for
export [53]. A series of scandals involving counterfeit
pharmaceutical exports in 2007 led to intense interna-
tional pressure on the Chinese government resulting in
the conviction and subsequent sentencing to death of the
country's two top drug regulators for accepting bribes
[54,55].Page 5 of 10
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counterfeiting syndicates, the result has often been vio-
lence. Enforcement officers in India [56] have been threat-
ened and shot at, and Dora Akunyili, the head of the
Nigerian National Agency for Food and Drug Administra-
tion and Control (NAFDAC) faced threats and violence
when she initiated an aggressive crackdown on counterfeit
medicine in 2000 [57]. In 2001 the NAFDAC laboratory
was vandalized and a policeman on duty killed. In 2003
an assassination attempt was made on Akunyili's life.
WHO has proactively tried to establish international
norms regulating pharmaceuticals and addressing the traf-
ficking of counterfeit products, although the result has
been less than fully successful. In the 1980s, the WHO ini-
tiated a voluntary, confidential international system to
report counterfeiting. However, countries were reluctant
to report and only a few did so [40]. In 1999, the WHO
developed guidelines to assist countries in implementing
effective regulation and monitoring of counterfeit medi-
cines [58]. In addition, a series of regional efforts were
launched to increase national capacity to combat counter-
feiting, since most countries do not have the capacity to
conduct the detailed chemical analysis required to deter-
mine the biological activity of imported drugs. For exam-
ple, a 2003 WHO initiative funded by Australia in
Cambodia, China, Laos, Burma, Thailand, and Vietnam
aimed to combat counterfeiting in the region, to promote
advocacy activities, and to strengthen inspection and post-
marketing surveillance [59]. In 2006 the WHO created the
International Medical Products Anti-Counterfeiting Task-
force (IMPACT) to increase international coordination of
efforts to monitor and combat counterfeit medicines.
However, like earlier, failed initiatives, participation is
voluntary and nonbinding [60].
Discussion
Almost 2 billion people lack access to essential medicines
[61]. Improving access to existing medicines could save 10
million lives each year [62]. Scientists, AIDS activists and
governments around the world responded with outrage to
the South African government's refusal to acknowledge
that HIV caused AIDS and that ARVs were effective and
life-prolonging. Yet that outrage has been inconsistent,
and the outcry in response to counterfeit medicines and
the promotion by the Presidents of The Gambia and Iran
of unproven AIDS remedies has been muted.
Government and UN Obligations
International legal standards impose on governments a
responsibility to respect, protect and fulfill certain enu-
merated rights of individuals. The right to life, to be pro-
tected from harm and exploitation, the right to the
progressive realization of access to health services, and the
right to receive and impart information are all relevant to
protection from unproven AIDS treatments and counter-
feit medicine.
The international recognition of the right to health began
with a reference to health in the United Nations Charter
and was affirmed in the preamble to the 1946 Constitu-
tion of the World Health Organization. The WHO Consti-
tution, in Article 21, empowers the World Health
Assembly to adopt regulations that are binding on Mem-
ber States related to, among other things, the safety, purity
and potency and the advertising and labeling of biologi-
cal, pharmaceutical, and "similar products" moving in
international commerce [63]. The global trafficking of
counterfeit medicines clearly falls within this protection,
and, as we have seen, unproven AIDS treatments are com-
monly promoted, tested, and shipped internationally as
well. The promotion of unproven 'cures' though, even
when not involving international commerce, can also be
covered by Article 19 of the WHO Constitution, which
states that the World Health Assembly "shall have the
authority to adopt conventions and agreements with
respect to any matter within the competence of the Organ-
ization". Article 19 was the basis for an international
framework convention on tobacco control, which was
first proposed in 1996, was adopted by consensus by
WHO's 192 member states in 2003, and entered into force
in February 2005 [64].
UN guidelines on HIV/AIDS and human rights emphasize
the need for states to take affirmative action to provide
adequate, accessible and effective HIV-related prevention
and care education, information and services. The guide-
lines say specifically:
States should take legislative and other measures to ensure that
medicines are supplied in adequate quantities and in a timely
fashion, and with accurate, current and accessible information
regarding their use. For example, consumer protection laws or
other relevant legislation should be enacted or strengthened to
prevent fraudulent claims regarding the safety and efficacy of
drugs, vaccines and medical devices, including those relating to
HIV [65].
In 2006, the United Nations issued a declaration on HIV/
AIDS committing all member states to pursue "all neces-
sary efforts" to scale up HIV/AIDS treatment programs
towards the goal of providing universal access to HIV/
AIDS treatment by 2010 [66]. UN member states have
also committed via the Millennium Development Goals
to work in cooperation with pharmaceutical companies to
ensure access to affordable essential drugs in developing
countries [67]. Reflecting on these commitments and
international human rights law, the UN Special Rappor-
teur on the Right to Health, Paul Hunt, has said unequiv-
ocally that: "access to medicines forms an indispensablePage 6 of 10
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health" and that the absence in states of regulation of
medicines is "clearly inconsistent with the right to the
highest attainable standard of health" [68].
Steps forward
The first step towards addressing unproven AIDS treat-
ments and counterfeit drugs must be to increase our
knowledge and understanding of the problem. The distri-
bution of medicines and 'cures' in developing countries
has long been recognized as chaotic and occurring
through commercial and other informal networks in addi-
tion to health care settings [69-73]. A number of research-
ers have also made the observation that most
pharmaceuticals, even ones intended to be strictly con-
trolled, are largely self-regulated [74,75]. More research
must therefore be conducted on the prevalence of
unproven 'cures', treatments and supplements, and on
PLWHA treatment-seeking behavior, specifically on the
extent to which unproven remedies delay uptake of ART
or complement it. Governments must conduct periodic
monitoring of the availability of unproven treatments on
the market and the claims made by promoters of such
treatments. The authenticity of ARV drugs must be regu-
larly monitored.
The second step is to continue to aggressively scale-up ART
programs and to widely promote their availability – to all
who need it, in an equitable and non-discriminatory man-
ner. Through the widespread promotion of ART and
expanding routine HIV testing linked to treatment, Bot-
swana has been able to achieve nearly universal knowl-
edge of, and confidence in ART as an effective treatment for
HIV/AIDS [76]; achieving the delivery of ART to 85% of
those in need [77]. In Zambia, by contrast, less than 30%
of women and men who need ART receive it [78], and
unproven AIDS 'cures' are common [4]. Most countries
will continue to fall short of the level of access to ART pro-
vided in Botswana, and uneven access will facilitate the
promotion of unproven medicines.
In most countries, information on ART is provided pas-
sively, by health care providers to those who are able to
access treatment. Outreach, provided through treatment
literacy campaigns emphasizing the effectiveness of ARV
drugs, the importance of adherence to prescribed regi-
mens, and the danger of untested 'cures' have been insuf-
ficiently funded, and have been largely implemented by
NGOs and networks of PLWHA. To be effective, these
campaigns must be expanded and conducted through
multiple channels, involving NGOs and PLWHA net-
works, but also public and private sector Western medical
providers, traditional healers, and mass media.
A third step would be for governments to enact or revise
legislation against counterfeit medicines and the fraudu-
lent promotion of unproven remedies. States must coop-
erate with international efforts to combat the trafficking of
counterfeit medicines and unproven cures. Alternatively,
the issue of counterfeit medicines and unproven remedies
could be addressed within a framework convention on
global health. Advocates for such a convention [79] stress
that this approach can foster capacity building of develop-
ing country health systems and facilitate international
cooperation towards addressing infectious disease control
and meeting basic health needs. Explicitly incorporating
counterfeit drugs and unproven therapies into the con-
vention could provide the fight against such treatments
with a universal definition of terms, the wider dissemina-
tion of reports of counterfeit drugs and unproven thera-
pies, and a requirement on states to report to the
international body steps taken to restrict the dissemina-
tion of such drugs and therapies.
Finally, WHO and UNAIDS must more forcefully pro-
mote the message that only ARV drugs have been proven
to be effective against AIDS, and must regularly and con-
sistently speak out and challenge governments that pro-
mote unproven 'cures' or fail to regulate claims of AIDS
treatments. Following the publication of a letter in
November 2007 by Human Rights Watch to the Kamran
Baqeri Lankarani, Iran's Minister of Health and Medical
Education concerning the promotion of IMOD [80], the
website promoting the 'cure' was taken down.
AIDS treatment in context
While the lack of universal access to ART is one factor in
the proliferation of unproven AIDS 'cures' and counterfeit
drugs, there are much broader considerations. ART, even
when recognized as life-saving and when widely available,
can not 'heal' all wounds experienced by those infected by
HIV. The promoters of unproven AIDS remedies – be they
traditional medical providers, faith healers, or Presidents
– often prey not only on the lack of understanding of ART,
but the broader fears and hopes of PLWHA for respect,
dignity, and a healthy future free from dependence,
stigma and discrimination. ART programs inevitably exist
in the political sphere and, as we have seen, governments
use the promotion of unproven AIDS remedies as part of
larger political campaigns to express benevolence or pro-
mote 'indigenous' solutions.
Paul Farmer has written eloquently about the introduc-
tion of ART in a rural clinic in Haiti, emphasizing the
hope felt by his patients upon receiving the drug and expe-
riencing the 'Lazarus'-like effects of it [81]. But Farmer has
also spoken about how the clinic's efforts include broader
social support and how this act of providing care to anPage 7 of 10
(page number not for citation purposes)
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ceived stigma.
Contrast Farmer's experience with that of modern, global,
faith healers such as the Canadian Benny Hinn who
promises deliverance from a wide range of ailments as
part of a ministry that is alleged to have revenues of $100
million per year. In 2007 Hinn preached in Uganda to a
crowd of 50,000 people at a football stadium. A journalist
attending the event interviewed a 19 year old woman liv-
ing with HIV who attended. She described how she was
living with her brother after her parents kicked her out of
her home when they discovered she was infected with
HIV. The article did not identify if the woman was taking
ART, but she clearly longed for more than just the medical
management of her condition. She said of Hinn: "He cured
me of AIDS, I can feel it. I just know"[82].
Everyone, everywhere, involved in the fight against AIDS
wants there to be a cure, and a cure as simple and as pain-
less as words spoken to a crowd at a football stadium. But
until a cure is found, ART represents our only form of life-
saving treatment. States and the global community have
committed billions of dollars to increasing access to effec-
tive medicine to fight AIDS, but have done little to address
unproven AIDS drugs and the threat of counterfeit ART.
The extent to which this failure represents actual harm is
as yet largely unknown, but the existence of it is an unfor-
tunate testament to the limitations of governments to ful-
fill their mandates to protect from harm and realize the
right to health of those living with HIV/AIDS.
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